Phase Ib/II study of capecitabine 7/7 schedule with neratinib in patients with HER2-positive metastatic breast cancer (MBC)R. Wang,J. Singh, V. Sterlin,M. Goldstein,D. Lake,S. Wong,J. Baselga, L. Norton,C. DangCANCER RESEARCH（2019）引用 1|浏览34暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
